- Home
- TXMD vs VSTD Comparison
TXMD vs VSTD Comparison
Compare TXMD & VSTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- VSTD
- Stock Information
- Founded
- TXMD 2008
- VSTD 2016
- Country
- TXMD United States
- VSTD United States
- Employees
- TXMD N/A
- VSTD N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- VSTD Restaurants
- Sector
- TXMD Health Care
- VSTD Consumer Discretionary
- Exchange
- TXMD Nasdaq
- VSTD Nasdaq
- Market Cap
- TXMD 17.6M
- VSTD 17.9M
- IPO Year
- TXMD N/A
- VSTD 2022
- Fundamental
- Price
- TXMD $1.63
- VSTD $0.56
- Analyst Decision
- TXMD
- VSTD
- Analyst Count
- TXMD 0
- VSTD 0
- Target Price
- TXMD N/A
- VSTD N/A
- AVG Volume (30 Days)
- TXMD 166.8K
- VSTD 513.7K
- Earning Date
- TXMD 11-12-2025
- VSTD 11-14-2025
- Dividend Yield
- TXMD N/A
- VSTD N/A
- EPS Growth
- TXMD N/A
- VSTD N/A
- EPS
- TXMD 0.03
- VSTD N/A
- Revenue
- TXMD $2,796,000.00
- VSTD $13,902,861.00
- Revenue This Year
- TXMD $427.09
- VSTD N/A
- Revenue Next Year
- TXMD N/A
- VSTD N/A
- P/E Ratio
- TXMD $259.70
- VSTD N/A
- Revenue Growth
- TXMD 75.19
- VSTD 30.39
- 52 Week Low
- TXMD $0.70
- VSTD $0.40
- 52 Week High
- TXMD $2.44
- VSTD $5.63
- Technical
- Relative Strength Index (RSI)
- TXMD 55.64
- VSTD N/A
- Support Level
- TXMD $1.55
- VSTD N/A
- Resistance Level
- TXMD $2.08
- VSTD N/A
- Average True Range (ATR)
- TXMD 0.28
- VSTD 0.00
- MACD
- TXMD 0.01
- VSTD 0.00
- Stochastic Oscillator
- TXMD 48.69
- VSTD 0.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About VSTD Vestand Inc. Class A Common Stock
Vestand Inc is a California-based Vestand is a fast-growing restaurant operator expanding into the real estate investment and development sector. It is a PropTech company engaged in AI-driven real estate investment and security token offerings (STOs). It provides services such as Property Acquisition, Property Development, Financial Management, and Property Management.